Regencell Bioscience Holdings Ltd SEC filings RGC
Regencell Bioscience Holdings Ltd has 85 filings in SEC EDGAR's recent list, going back to Nov 13, 2020. Its latest annual report, Form 20-F, was filed on Oct 7, 2026 for the period ended Jun 30, 2026. The most recent current report (Form 6-K) was filed on May 22, 2026.
| Form | Description | Filed | Period |
|---|---|---|---|
| 20-F | Annual report (foreign issuer) | Oct 7, 2026 | Jun 30, 2026 |
| 20-F | Annual report (foreign issuer) | Oct 31, 2025 | Jun 30, 2025 |
| 20-F | Annual report (foreign issuer) | Oct 25, 2024 | Jun 30, 2024 |
| 20-F | Annual report (foreign issuer) | Oct 27, 2023 | Jun 30, 2023 |
| 20-F | Annual report (foreign issuer) | Oct 31, 2022 | Jun 30, 2022 |
| 20-F | Annual report (foreign issuer) | Oct 29, 2021 | Jun 30, 2021 |
Showing 6 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- RGC (Nasdaq)
- Incorporated in
- Cayman Islands
- Headquarters
- Hong Kong
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1829667
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
- Aurora Cannabis Inc ACB
Source: SEC EDGAR filings. This is company-reported data, not investment advice.